Log in to save to my catalogue

Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases

Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4562e34fbfb04caf8211fba3f76a7a82

Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases

About this item

Full title

Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases

Publisher

Switzerland: MDPI AG

Journal title

Molecules (Basel, Switzerland), 2022-03, Vol.27 (7), p.2048

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

The binding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein to its cellular receptor, the angiotensin-converting enzyme 2 (ACE2), causes its downregulation, which subsequently leads to the dysregulation of the renin–angiotensin system (RAS) in favor of the ACE–angiotensin II (Ang II)–angiotensin II type I rece...

Alternative Titles

Full title

Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4562e34fbfb04caf8211fba3f76a7a82

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4562e34fbfb04caf8211fba3f76a7a82

Other Identifiers

ISSN

1420-3049

E-ISSN

1420-3049

DOI

10.3390/molecules27072048

How to access this item